US and EU join efforts to accelerate progress in immunotherapies: interview with Prof. Hortobagyi
Chaired by Professor Gabriel Hortabogyi [1] and Professor Fabrice André [2], the 2016 edition of the BIG-NABCG annual meeting took place in Chicago on 1-2 June and focused its discussions on the role of immunotherapy in breast cancer research and treatment. Insights into this intensive meeting and the trans-Atlantic collaboration are described here by Dr Gabriel Hortobagyi.

'There are multiple avenues of immunological intervention that could be explored.[...] A division of labour would move the field forward faster than independent and uncoordinated efforts.'